Coordinated COVID-19 Research Activities and Initiatives across BC
BC’s health research community is collaborating to provide a coordinated, strategic approach to the COVID-19 pandemic that supports decision makers, patients, public and others.
This page serves as a resource identifying research efforts underway and planned, and supports participating organizations in communicating their work in the context of a coordinated provincial health research response.
If you are a researcher or researcher leader, you can help support BC’s coordinated research approach.
- The BC COVID-19 Strategic Research Advisory Committee
- Michael Smith Foundation for Health Research
- MSFHR COVID-19 Research Response Fund (Partnering with Population Data BC for projects that require data services and BC Academic Health Science Network for projects that involve patient engagement).
- Strategic Support to BC COVID-19 Strategic Research Advisory Committee (SRAC).
- KT Pathway's COVID-19 Provincial KT Resource Hub
- Partnering with CIHR and other funders on research important to BC.
- Exploring ways to co-fund COVID-19 research important to BC with other funders and partners.
BC Academic Health Science Network
Partnering on Genome Canada’s COVID-19 Regional Genomics Initiative.
Partnering on Genome Canada’s Canadian COVID Genomics Network (CanCOGeN).
Exploring ways to co-fund COVID-19 research important to BC, including through its Emerging Issues Fund and its GeneSolve Program that brings industry and academia together to find solutions to challenges.
University of British Columbia
COVID-19 Clinical Research Coordination Initiative (CRCI), a province-wide program focused on translational research aimed at capturing and collating collective input and feedback: including:
Need for a provincial COVID-19 biobank (in development).
Creating partnership with REACH BC to establish a provincial platform for patient participation in COVID-19 research.
Maintaining an inventory of active COVID-19 funding opportunities designed to support researchers and their teams.
BC’s health authorities are contributing data and clinical research participants to inform provincial analytic and research efforts, as well as conducting their own clinical trials and/or serving as clinical trials sites.
The Health Research Council of BC
- The Health Research Council of BC represents the research leaders of BC’s health authorities, research-intensive universities, funders and government, and serves as a feedback mechanism for SRAC and for communicating initiatives across BC’s research community.
Help support BC’s coordinated health research response
Research activities and existing coordination efforts are led by a range of individuals and organizations, and serve as valuable components of BC’s coordinated research response. Leaders of initiatives are encouraged to review and add to the list, and further connect themselves to the provincial response through the following means:
- Using and adding to the BC Inventory of COVID-19 Research
- Aligning efforts where appropriate with the BC COVID-19 Strategic Research Framework
- Calling on SRAC to provide advice on research priorities, mechanisms for coordination, and other elements of a provincial research response to COVID-19 (Contact via MSFHR secretariat (firstname.lastname@example.org)
- Sharing your work with SRAC (email@example.com)
- Communicating your work in the context of a coordinated provincial response
Select COVID-19 research activities and initiatives in Canada
- McMaster University
- The COVID-19 Evidence Network to support Decision-making (COVID-END) provides resources to support decision-makers and researchers to find and use the best evidence that is already out there and to help reduce duplication in and better coordinate the evidence syntheses, technology assessment and guidelines being produced.
- Government of Canada
- CanCOVID is an expert network of Canadian COVID-19 researchers, clinical collaborators, and healthcare stakeholders from across the country. Canada’s Chief Science Officer mandated the creatin of CanCOVID to expedite communication and collaboration between the scientific, healthcare and policy communities during the COVID-19 crisis.
- Canadian Institutes of Health Research
- Canadian COVID-19 Human Host Genome Sequencing (HostSeq) Program (CGEn)
- The Canadian federal government announced $20 million in funding to CGEn for a COVID-19 Host Genome Sequencing Program (see Press Release here). This announcement was part of a larger Canadian network, CanCOGeN, that also include sequencing the SAR-CoV-2 viral sequencing. This is a 2-year program that will requires swift and smart decisions to be delivered on time and with maximum impact
- CGEn has been specifically tasked to sequence the genomes of 10,000 Canadians to help understand the genomic architecture of the host response to COVID-19, with data linked to clinical and medical information and build a Canadian genomic data resource that is accessible to Canadian researchers and will aid in studying genetic risk factors associated with the response to and severity of COVID-19.
- CGEn will provide free sequencing to eligible studies enrolled in the HostSeq project and ensure that samples entering the HostSeq initiative are sourced from a broad network of researchers/clinicians across Canada, working on a range of COVID-19 related research. The HostSeq SR sub-committee is currently chaired by Dr. Stuart Turvey.
- COVID-19 Mental Health Research
- To support the mental health of all Canadians and address the increase in needs during this unprecedented time, Canadian Institutes of Health Research (CIHR) developed a COVID-19 and Mental Health (CMH) Initiative, which includes a searchable database of knowledge syntheses and lay summaries of current evidence on mental health services' needs, delivery and guidelines, practice and related issues in the COVID-19 context for policy makers, practitioners, researchers and all Canadians.
- The site features preliminary COVID-19 mental health knowledge syntheses and lay summaries. It's dedicated to the rapid dissemination of crucial mental health and substance use knowledge in the COVID-19 context.